Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perlemax develops advanced microbubble technologies spun out from the University of Sheffield to improve mass transfer processes in gas-liquid systems. Their innovations enable significant energy savings and process improvements across wastewater treatment, biorefining, algae cultivation using CO₂-rich exhaust gases, ammonia stripping from leachate/aquaculture water, enhanced anaerobic digestion for biogas production, and plasma-based ozone generation. The company has won several innovation awards and collaborates widely with industry partners on demonstration-scale projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perlemax.